Uterine cancer treatment cost in Poland typically depends on the surgical approach and disease stage. Diagnostic procedures like a PET-CT scan range from $800 to $1,200, while a primary hysterectomy (uterus removal) costs $6,000 to $11,000. Specialized methods such as a laparoscopic hysterectomy run from $6,000 to $10,000. Patients can save approximately 40-60% compared to US prices in major medical hubs like Warsaw, Krakow, and Wroclaw.
Typical Uterine Cancer Treatment Costs in Poland
Bookimed Expert Insight: Patients seeking advanced precision should consider centers with CyberKnife technology, like the Institute of Cybernetic Surgery. For complex cases involving heart conditions, European Health Center Otwock offers a unique interdisciplinary cardio-oncology department. Large multidisciplinary facilities, such as University Hospital in Krakow, are best for high-volume surgical expertise. These centers handle over 450,000 patients annually using extensive specialist teams.
| Poland | Turkey | Austria | |
| Laparoscopic Hysterectomy | from $6,000 | from $7,000 | from $15,000 |
| Hysterectomy (uterus removal) | from $6,000 | from $4,760 | from $15,000 |
| Hormone therapy | from $1,800 | from $407 | from $7,000 |
| Hysterectomy with DaVinci robot | from $12,000 | from $11,000 | from $16,000 |
| Radiotherapy for uterine cancer | - | from $4,000 | from $6,975 |
No hidden fees – just official clinic prices. Pay at the clinic for Uterine cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Uterine cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Uterine cancer treatment journey.
Standard uterine cancer treatment in Poland follows national oncology guidelines, prioritizing surgery and precision-based medicine. Primary care involves laparoscopic or robot-assisted hysterectomy. Advanced cases receive targeted immunotherapy or chemotherapy. Specialized centers like University Hospital in Krakow utilize molecular staging to personalize radiation and systemic protocols.
Bookimed Expert Insight: While many patients look for private clinics, Poland's large academic centers like University Hospital in Krakow serve over 450,000 patients annually. These high-volume public-private facilities often house the most specialized equipment, like the CyberKnife in Wieliszew. This volume ensures surgeons maintain high proficiency in complex oncological procedures.
Patient Consensus: Patients note that final pathology results often change the initial surgical plan. Many feel relieved when early-stage findings allow for surgery without immediate chemotherapy.
Poland follows international protocols for advanced or recurrent endometrial cancer. Local guidelines from the Polish Society of Gynecological Oncology align with European ESGO and American NCCN frameworks. Treatment integrates FIGO staging and mandatory molecular profiling to guide surgery, immunotherapy, and targeted treatments.
Bookimed Expert Insight: Poland offers high-capacity oncology care through centers like University Hospital in Krakow. It treats 455,000 patients every year. Our data shows specialized centers like the European Health Center Otwock focus on complex cases. They even have dedicated cardio-oncology departments. Patients should look for these specialized academic centers. They often have faster access to the latest international drug protocols.
Patient Consensus: Patients note that major centers follow standard pathways. They recommend asking for molecular testing like MMR or p53 early. Many suggest getting a second opinion if facing recurrent disease. They also say large academic systems offer better access to the newest treatments.
Poland hosts active clinical trials for advanced or recurrent uterine cancer within international multi-center studies. Patients can access novel immunotherapies and targeted agents at high-volume oncology clusters. Leading sites include those in Warsaw and Krakow. Participation often requires specific molecular profiling for enrollment eligibility.
Bookimed Expert Insight: Poland serves as a strategic hub for large-scale European trials, often providing early access to therapies before general approval. University Hospital in Krakow alone serves 455,000 patients annually. This massive patient volume attracts international phase III studies. Patients should prioritize these centralized academic hubs for advanced therapy options.
Patient Consensus: Patients note that access often depends on tumor biomarkers like MSI-H or HER2 status. Many recommend seeking second opinions at major academic centers to uncover trial eligibility early.
Medical tourists should plan to remain in Poland for 10 to 21 days following uterine cancer surgery. This duration covers the initial hospital stay and essential recovery. It ensures surgeons can monitor incisions, review pathology reports, and clear the patient for safe air travel.
Bookimed Expert Insight: Poland offers unique specialized centers like the European Health Center Otwock which focuses on cardio-oncology. This is vital for patients with heart conditions undergoing uterine cancer treatment. When choosing a clinic, check if they use the DaVinci robot. This technology often allows for shorter hospital stays compared to traditional surgery.
Patient Consensus: Patients emphasize that pathology results are the main factor in how long you must stay. Many recommend traveling with a companion because managing heavy luggage at the airport is difficult after pelvic surgery.